{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:22:20Z","timestamp":1789183340191,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004441","name":"Swedish International Development Cooperation Agency","doi-asserted-by":"crossref","award":["75000553"],"award-info":[{"award-number":["75000553"]}],"id":[{"id":"10.13039\/100004441","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bolivia has the highest prevalence of cervical cancer in South America and the prevalence of viral sexually transmitted infections (STIs) among people in urban cities is increasing. Little is known about the prevalence of viral STIs in rural communities, which generally have limited access to health care. In order to study the prevalence of viral STIs in rural Bolivia, we recruited women from villages and towns in the Department of La Paz in Bolivia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Three hundred ninety-four female participants were assessed for IgG-antibodies to herpes simplex virus type 2 (HSV-2), human immunodeficiency virus (HIV) and hepatitis B virus (HBV, anti-HBc), as well as for the presence of HBV surface antigen (HBsAg) in dried blood spots. The prevalence of 12 high-risk types of human papillomavirus (HPV) was assessed by qPCR in dried cervicovaginal cell spots from 376 of these women. \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      test was used to compare variables between the populations and binary logistic regression was used to identify risk factors associated with the positivity of the tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The seroprevalence of HSV-2 was 53% and of HBV 10.3%. HBAg was detected in 15.8% of women with anti-HBV antibodies indicating chronic infection. The frequency of high-risk HPV infection was 27%, with the most prevalent high-risk HPV types being HPV 56, 39 and 31 followed by HPV 16 and 18. Finally, none of the 394 women were seropositive for HIV, and about 64% of the studied population was positive for at least one of the viral infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Women in Bolivian rural communities in La Paz show a high prevalence of HBV, HPV and, in particular, HSV-2. In contrast, none of the women were HIV positive, suggesting that the HIV prevalence in this population is low. The pattern of high-risk HPV types differed from many other countries with a predominance of HPV-types not included in the Gardasil vaccine which was officially introduced in Bolivia in April 2017.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-4931-1","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T13:02:57Z","timestamp":1583499777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of viral sexually transmitted infections and HPV high-risk genotypes in women in rural communities in the Department of La Paz, Bolivia"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1853-5287","authenticated-orcid":false,"given":"Marianela","family":"Patzi-Churqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katty","family":"Terrazas-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-\u00c5ke","family":"Liljeqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Lindh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"issue":"6 Suppl","key":"4931_CR1","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.contraception.2014.06.024","volume":"90","author":"N Ortayli","year":"2014","unstructured":"Ortayli N, Ringheim K, Collins L, Sladden T. Sexually transmitted infections: progress and challenges since the 1994 international conference on population and development (ICPD). Contraception. 2014;90(6 Suppl):S22\u201331.","journal-title":"Contraception"},{"issue":"1","key":"4931_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114989","volume":"10","author":"KJ Looker","year":"2015","unstructured":"Looker KJ, Magaret AS, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015;10(1):e114989.","journal-title":"PLoS One"},{"key":"4931_CR3","unstructured":"World Health Organization (WHO). Global hepatitis report. 2017. [http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255016\/9789241565455-eng.pdf?sequence=1].\u00a0Accessed 30 Aug 2019."},{"issue":"9525","key":"4931_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(06)68808-9","volume":"367","author":"RA Montenegro","year":"2006","unstructured":"Montenegro RA, Stephens C. Indigenous health in Latin America and the Caribbean. Lancet. 2006;367(9525):1859\u201369.","journal-title":"Lancet"},{"issue":"5","key":"4931_CR5","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"key":"4931_CR6","unstructured":"Pardo I. Gu\u00eda de tamizaje de cancer de cuello uterino y mama. 2013. [https:\/\/www.minsalud.gob.bo\/images\/Documentacion\/dgss\/Area_Continuo\/LIBRO%20GUIA%20TAMIZAJE.pdf].\u00a0Accessed Sept 2019."},{"issue":"1","key":"4931_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1590\/S1020-49892005000600012","volume":"18","author":"IG Dzuba","year":"2005","unstructured":"Dzuba IG, Calderon R, Bliesner S, Luciani S, Amado F, Jacob M. A participatory assessment to identify strategies for improved cervical cancer prevention and treatment in Bolivia. Rev Panam Salud Publica. 2005;18(1):53\u201363.","journal-title":"Rev Panam Salud Publica"},{"key":"4931_CR8","unstructured":"The Pan American Health Organization (PAHO). Bolivia intensifica vacunaci\u00f3n contra el Virus del Papiloma Humano 2019. [https:\/\/www.paho.org\/bol\/index.php?option=com_content&view=article&id=2328:bolivia-intensifica-vacunacion-contra-el-virus-del-papiloma-humano&Itemid=481].\u00a0Accessed 01 Jan 2020."},{"issue":"Suppl 1","key":"4931_CR9","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/S1386-6532(05)80022-8","volume":"34","author":"R Parana","year":"2005","unstructured":"Parana R, Almeida D. HBV epidemiology in Latin America. J Clin Virol. 2005;34(Suppl 1):S130\u20133.","journal-title":"J Clin Virol"},{"issue":"1","key":"4931_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12889-017-4227-6","volume":"17","author":"AM Ropero \u00c1lvarez","year":"2017","unstructured":"Ropero \u00c1lvarez AM, P\u00e9rez-Vilar S, Pacis-Tirso C, Contreras M, El Omeiri N, Ruiz-Matus C, Velandia-Gonz\u00e1lez M. Progress in vaccination towards hepatitis B control and elimination in the region of the Americas. BMC Public Health. 2017;17(1):325.","journal-title":"BMC Public Health"},{"key":"4931_CR11","unstructured":"Gomez-D\u00e1vila C. HOY HABLAMOS DEL SIDA. 2018. [https:\/\/www.idhbolivia.org\/images\/noticias\/2018\/DATOSVIHSIDA2017.pdf].\u00a0Accessed Aug 2019."},{"issue":"4","key":"4931_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bjid.2015.04.002","volume":"19","author":"C Ter\u00e1n Calder\u00f3n","year":"2015","unstructured":"Ter\u00e1n Calder\u00f3n C, Gorena Urizar D, Gonz\u00e1lez Bl\u00e1zquez C, Alejos Ferreras B, Ram\u00edrez Rubio O, Bolumar Montrull F, Ortiz Rivera M, del Amo VJ. Knowledge, attitudes and practices on HIV\/AIDS and prevalence of HIV in the general population of Sucre, Bolivia. Braz J Infect Dis. 2015;19(4):369\u201375.","journal-title":"Braz J Infect Dis"},{"key":"4931_CR13","unstructured":"Consejo Indigena del pueblo Tacana (CIPTA). Plan de gestion territorial ind\u00edgena del pueblo TACANA 2015-2025. 2014. [https:\/\/searchworks.stanford.edu\/view\/11347692].\u00a0Accessed 23 Sept 2019."},{"key":"4931_CR14","doi-asserted-by":"crossref","unstructured":"Gruner N, Stambouli O, Ross RS. Dried blood spots--preparing and processing for use in immunoassays and in molecular techniques. J Vis Exp. 2015;97.","DOI":"10.3791\/52619"},{"issue":"12","key":"4931_CR15","doi-asserted-by":"publisher","first-page":"E533","DOI":"10.1111\/1469-0691.12292","volume":"19","author":"D Kania","year":"2013","unstructured":"Kania D, Bekale AM, Nagot N, Mondain AM, Ottomani L, Meda N, Traore M, Ouedraogo JB, Ducos J, Van de Perre P, et al. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso. West Africa Clin Microbiol Infect. 2013;19(12):E533\u201341.","journal-title":"West Africa Clin Microbiol Infect"},{"issue":"4","key":"4931_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jcv.2011.05.006","volume":"51","author":"I Gustavsson","year":"2011","unstructured":"Gustavsson I, Sanner K, Lindell M, Strand A, Olovsson M, Wikstrom I, Wilander E, Gyllensten U. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol. 2011;51(4):255\u20138.","journal-title":"J Clin Virol"},{"issue":"6","key":"4931_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1469-0691.2004.00836.x","volume":"10","author":"R Ashley-Morrow","year":"2004","unstructured":"Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J. Performance of Focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect. 2004;10(6):530\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"4931_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jiph.2018.10.007","volume":"12","author":"S Garc\u00eda-Cisneros","year":"2019","unstructured":"Garc\u00eda-Cisneros S, S\u00e1nchez-Alem\u00e1n M\u00c1, Conde-Glez CJ, Lara-Zaragoza SJ, Herrera-Ortiz A, Plett-Torres T, Olamendi-Portugal M. Performance of ELISA and Western blot to detect antibodies against HSV-2 using dried blood spots. J Infect Public Health. 2019;12(2):224\u20138.","journal-title":"J Infect Public Health"},{"issue":"6","key":"4931_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1128\/CVI.00051-06","volume":"13","author":"S Gorander","year":"2006","unstructured":"Gorander S, Mbwana J, Lyamuya E, Lagergard T, Liljeqvist JA. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts. Clin Vaccine Immunol. 2006;13(6):633\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"4931_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcv.2007.09.009","volume":"40","author":"M Lindh","year":"2007","unstructured":"Lindh M, Gorander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W. Real-time Taqman PCR targeting 14 human papilloma virus types. J Clin Virol. 2007;40(4):321\u20134.","journal-title":"J Clin Virol"},{"issue":"10","key":"4931_CR21","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/infdis\/jiy075","volume":"217","author":"DA Machalek","year":"2018","unstructured":"Machalek DA, Garland SM, Brotherton JML, Bateson D, McNamee K, Stewart M, Rachel Skinner S, Liu B, Cornall AM, Kaldor JM, et al. Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 years following implementation of vaccination. J Infect Dis. 2018;217(10):1590\u2013600.","journal-title":"J Infect Dis"},{"issue":"1","key":"4931_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12879-017-2674-4","volume":"17","author":"JW Domercant","year":"2017","unstructured":"Domercant JW, Jean Louis F, Hulland E, Griswold M, Andre-Alboth J, Ye T, Marston BJ. Seroprevalence of herpes simplex virus type-2 (HSV-2) among pregnant women who participated in a national HIV surveillance activity in Haiti. BMC Infect Dis. 2017;17(1):577.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"4931_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/sti.79.6.460","volume":"79","author":"A Rodriguez","year":"2003","unstructured":"Rodriguez A, Castle P, Smith J, Bratti C, Hildesheim A, Schiffman M, Viscidi R, Burk R, Ashley R, Castellsague X, et al. A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica. Sex Transm Infect. 2003;79(6):460\u20135.","journal-title":"Sex Transm Infect"},{"issue":"3","key":"4931_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/sextrans-2015-052072","volume":"92","author":"L Masson","year":"2016","unstructured":"Masson L, Arnold KB, Little F, Mlisana K, Lewis DA, Mkhize N, Gamieldien H, Ngcapu S, Johnson L, Lauffenburger DA, et al. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection. Sex Transm Infect. 2016;92(3):186\u201393.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"4931_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/sti.79.4.286","volume":"79","author":"FM Cowan","year":"2003","unstructured":"Cowan FM, French RS, Mayaud P, Gopal R, Robinson NJ, de Oliveira SA, Faillace T, Uusk\u00fcla A, Nyg\u00e5rd-Kibur M, Ramalingam S, et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect. 2003;79(4):286.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"4931_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1071\/SH09098","volume":"7","author":"AG Brazzale","year":"2010","unstructured":"Brazzale AG, Russell DB, Cunningham AL, Taylor J, McBride WJ. Seroprevalence of herpes simplex virus type 1 and type 2 among the indigenous population of Cape York, far North Queensland, Australia. Sex Health. 2010;7(4):453\u20139.","journal-title":"Sex Health"},{"issue":"1","key":"4931_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-015-1837-x","volume":"9","author":"B Daniels","year":"2016","unstructured":"Daniels B, Wand H, Ramjee G. Prevalence of herpes simplex virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban. S Afr BMC Res Notes. 2016;9(1):1\u20138.","journal-title":"S Afr BMC Res Notes"},{"issue":"12","key":"4931_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050384","volume":"7","author":"J Stieglitz","year":"2012","unstructured":"Stieglitz J, Blackwell AD, Quispe Gutierrez R, Cortez Linares E, Gurven M, Kaplan H. Modernization, sexual risk-taking, and gynecological morbidity among Bolivian forager-horticulturalists. PLoS One. 2012;7(12):e50384.","journal-title":"PLoS One"},{"issue":"2","key":"4931_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/oxfordjournals.aje.a114238","volume":"123","author":"MV Zunzunegui","year":"1986","unstructured":"Zunzunegui MV, King MC, Coria CF, Charlet J. Male influences on cervical cancer risk. Am J Epidemiol. 1986;123(2):302\u20137.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"4931_CR30","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1016\/S2214-109X(15)00086-8","volume":"3","author":"Mary K Grabowski","year":"2015","unstructured":"Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, et al. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda. Lancet Global Health. 3(8):e478\u201386.","journal-title":"The Lancet Global Health"},{"issue":"2","key":"4931_CR31","first-page":"135","volume":"2","author":"CH Lema","year":"2001","unstructured":"Lema CH, Hurtado LV, Segurondo D, Romero F, Dulon A, Asturizaga D, Panoso W, Garcia G, Fujiyoshi T, Yashiki S, et al. Human papillomavirus infection among Bolivian Amazonian women. Asian Pac J Cancer Prev. 2001;2(2):135\u201341.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4931_CR32","unstructured":"Ter\u00e1n Calder\u00f3n C. Prevalencia y factores asociados a la infecci\u00f3n por el virus del papiloma humano (VPH) y las lesiones causadas por el mismo en mujeres de 20 a 59 a\u00f1os en el municipio de Sucre, Bolivia. Universidad de Alcal\u00e1, 2014. [https:\/\/dialnet.unirioja.es\/servlet\/tesis?codigo=113987].\u00a0Accessed Aug 2019."},{"issue":"1","key":"4931_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12889-019-6401-5","volume":"19","author":"G Allende","year":"2019","unstructured":"Allende G, Surriabre P, C\u00e1ceres L, Bellot D, Ovando N, Torrico A, Calle P, Ascarrunz C, Alexander S, Bossens M, et al. Evaluation of the self-sampling for cervical cancer screening in Bolivia. BMC Public Health. 2019;19(1):80.","journal-title":"BMC Public Health"},{"issue":"11","key":"4931_CR34","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1086\/428779","volume":"191","author":"PE Castle","year":"2005","unstructured":"Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis. 2005;191(11):1808\u201316.","journal-title":"J Infect Dis"},{"issue":"9312","key":"4931_CR35","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","volume":"359","author":"N Munoz","year":"2002","unstructured":"Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359(9312):1093\u2013101.","journal-title":"Lancet"},{"issue":"9490","key":"4931_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991\u20138.","journal-title":"Lancet"},{"issue":"2","key":"4931_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/00365548.2010.526957","volume":"43","author":"T Ramqvist","year":"2011","unstructured":"Ramqvist T, Du J, Lunden M, Ahrlund-Richter S, Ferreira J, Marions L, Sparen P, Andersson S, Dalianis T. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm. Sweden Scand J Infect Dis. 2011;43(2):115\u201321.","journal-title":"Sweden Scand J Infect Dis"},{"issue":"1","key":"4931_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","volume":"13","author":"CM Wheeler","year":"2012","unstructured":"Wheeler CM, Castellsagu\u00e9 X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmer\u00f3n J, Chow S-N, Apter D, Kitchener H, et al. Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13(1):100\u201310.","journal-title":"Lancet Oncol"},{"issue":"10","key":"4931_CR39","doi-asserted-by":"publisher","first-page":"e0181643","DOI":"10.1371\/journal.pone.0181643","volume":"12","author":"CM Jaramillo","year":"2017","unstructured":"Jaramillo CM, de La Hoz F, Porras A, di Filippo D, Choconta-Piraquive LA, Payares E, Montes N, Navas M-C. Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas state. Colombia PLoS One. 2017;12(10):e0181643.","journal-title":"Colombia PLoS One"},{"issue":"1","key":"4931_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.virusres.2007.12.005","volume":"132","author":"A Khan","year":"2008","unstructured":"Khan A, Tanaka Y, Saito H, Ebinuma H, Sekiguchi H, Iwama H, Wakabayashi G, Kamiya T, Kurbanov F, Elkady A, et al. Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia. Virus Res. 2008;132(1):174\u201380.","journal-title":"Virus Res"},{"key":"4931_CR41","unstructured":"Ministerio de Salud y Deportes, and ITS\/VIH\/SIDA PN. Prevalencia e incidencia de VIH\/SIDA (estimaciones con el modelo epidemiol\u00f3gico del EPP-Spectrum) \"Vigilancia Centinela\". 2016. [https:\/\/www.minsalud.gob.bo\/1531-presentan-resultados-de-vigilancia-centinela-sobre-transmision-materno-infantil-del-vih-y-sifilis].\u00a0Accessed Sept 2019."},{"issue":"1","key":"4931_CR42","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12885-017-3734-2","volume":"17","author":"S Li","year":"2017","unstructured":"Li S, Wen X. Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999\u20132014). BMC Cancer. 2017;17(1):726.","journal-title":"BMC Cancer"},{"issue":"21","key":"4931_CR43","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/jnci\/94.21.1604","volume":"94","author":"JS Smith","year":"2002","unstructured":"Smith JS, Herrero R, Bosetti C, Mu\u00f1oz N, Bosch FX, Eluf-Neto J, Castellsagu\u00e9 X, Meijer CJLM, Van den Brule AJC, Franceschi S, et al. Herpes simplex Virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical Cancer. JNCI: J Natl Cancer Institute. 2002;94(21):1604\u201313.","journal-title":"JNCI: J Natl Cancer Institute"},{"issue":"12","key":"4931_CR44","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/jmv.23353","volume":"84","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Cao X, Zheng Y, Tang J, Cai W, Wang H, Gao Y, Wang Y. Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2. J Med Virol. 2012;84(12):1920\u20137.","journal-title":"J Med Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4931-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T19:25:19Z","timestamp":1614972319000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4931-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4931"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4931-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.15321\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.15321\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.15321\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"23 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the participants gave written or signed informed consent to participate in the study. Eligible minor participants had consent from a parent or guardian who sign the informed consent prior to inclusion in the study. Ethical committee at Universidad Mayor de San Andr\u00e9s in La Paz, Bolivia approved the project study \u201cInfecciones virales tropicales\u201d with an ethical permission CEI-UMSA 0215. The biological material shipment to and analysis in Sweden was in agreement between the main coordination at University of Gothenburg and Universidad Mayor de San Andr\u00e9s.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}